Celcuity News - CELC

Company Name	Stock Ticker Symbol	Market	Type
Celcuity Inc	CELC	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.62	-3.64%	16.39	17:30:02

Open Price	Low Price	High Price	Close Price	Prev Close
16.99	16.31	16.99	16.39	17.01

more quote information »

Recent News

Date	Time	Source	Heading
4/04/2024	07:05	GLOBE	Celcuity To Present at Upcoming Needham and Stifel Investor..
3/27/2024	16:01	GLOBE	Celcuity Inc. Reports Fourth Quarter and Full Year 2023..
3/20/2024	07:05	GLOBE	Celcuity Inc. Schedules Release of Fourth Quarter and Full..
3/06/2024	07:05	GLOBE	Celcuity to Participate in Leerink Partners Global Biopharma..
2/28/2024	07:05	GLOBE	Celcuity to Participate in Cowen’s 44th Annual Health Care..
2/23/2024	16:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	16:05	GLOBE	Celcuity Announces First Patient Dosed in Phase 1b/2..
2/20/2024	07:05	GLOBE	Celcuity Appoints Eldon Mayer as Chief Commercial Officer
2/15/2024	17:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	17:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	20:28	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/09/2024	10:32	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/07/2024	17:15	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/22/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	10:34	EDGAR2	Form 144 - Report of proposed sale of securities
12/06/2023	08:30	GLOBE	Celcuity Presents Preclinical Data on Therapeutic Effects of..
12/05/2023	17:25	EDGAR2	Form 8-K - Current report
12/01/2023	11:02	GLOBE	Celcuity to Present Preclinical Data for Gedatolisib at the..
11/30/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/29/2023	16:30	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/29/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/22/2023	08:15	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
11/22/2023	08:05	GLOBE	Celcuity to Participate in the 6th Annual Evercore ISI..
11/13/2023	14:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	07:35	EDGAR2	Form 8-K - Current report
11/13/2023	07:05	GLOBE	Celcuity Inc. Reports Third Quarter 2023 Financial Results..
11/06/2023	07:30	GLOBE	Celcuity Inc. Schedules Release of Third Quarter 2023..
11/01/2023	07:05	GLOBE	Celcuity To Present at Upcoming Stifel and Jefferies..
10/27/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/23/2023	17:15	EDGAR2	Form 8-K - Current report
9/07/2023	16:05	GLOBE	Celcuity to Host Virtual Science Day for Investors
9/01/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	10:58	EDGAR2	Form 144 - Report of proposed sale of securities
8/29/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	16:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	17:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/22/2023	17:15	EDGAR2	Form 8-K - Current report
8/22/2023	16:05	GLOBE	Celcuity Enters into a Clinical Trial Collaboration and..
8/22/2023	16:01	GLOBE	Celcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial..
8/11/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:10	EDGAR2	Form 8-K - Current report
8/10/2023	16:04	GLOBE	Celcuity Inc. Reports Second Quarter 2023 Financial Results..
8/03/2023	07:30	GLOBE	Celcuity Inc. Schedules Release of Second Quarter 2023..
7/31/2023	08:00	GLOBE	Celcuity to Participate in the BTIG Virtual Biotechnology..